Friday, 13 July 2018

Global Therapeutic Landscape of Cell Therapy Market Pipeline Review, 2018


Market Scenario
Cell therapy has come forward as a recent phase of the biotechnology revolution in medical sector. As cell therapy is based on ground-breaking scientific discoveries and various technological advancements. The main aim of cell therapy is to target various diseases at the cellular level by restoring a certain cell population as carriers of therapeutic cargo. It is also used in combination with gene therapy for many diseases. For many diseases, gene and cell therapy are applied in combination.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5066

With new technologies, and different types of cells such as hematopoietic stem cells (HSC), mesenchymal stem cells, skeletal muscle stem cells, lymphocytes, pancreatic islet cells, and dendritic cells, cell therapy can be used for the treatment of a variety of diseases. Hematopoietic stem cell transplantation or Bone marrow transplant is the most commonly used cell therapy to treat a variety of hematologic conditions and blood cancers. Potential applications of cell therapy include treatment of cancers, urinary problems, autoimmune disease, and infectious disease, repairing spinal cord injuries, rebuilding damaged cartilage in joints, improving the immune system, and treatment of neurological disorders.
Adipose tissue-derived stem cells (ADSCs) are another most promising cell types for application in regenerative therapies. Regenerative medicine is an interdisciplinary field comprises of tissue engineering, with an objective of restoration or establishment of the normal functioning of organs.
It is estimated that cell therapy market is expected to grow at a CAGR 10.6% during the forecast period of 2017-2023.
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/5066

Segmentation
The cell therapy market is segmented on the basis of type, technology, cell source, application, and end-user.
On the basis of type, the market is segmented into autologous, and allogeneic.
On the basis of technology, the market is classified into somatic cell technology, cell immortalization technology, viral vector technology, genome editing technology, cell plasticity technology, and three-dimensional technology. Viral vector technology is further segmented into Ex vivo gene modification of cells and In vivo gene modification of cells.
On the basis of cell source, the market is classified into induced pluripotent stem cells (iPSCs), bone marrow, umbilical cord blood-derived cells, adipose tissue, and neural stem cell.
On the basis of application, the market is classified into musculoskeletal, cardiovascular, gastrointestinal, neurological, oncology, dermatology, wounds and injuries, ocular, and others.
On the basis of end-users, the market is segmented into hospital & clinics, regenerative medicine centers, diagnostic centers, research institutes, and others.
Detailed Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
LIST OF TABLES
Table 1 Cell Therapy Industry Synopsis, 2017 – 2023
Table 2 Cell Therapy Market Estimates And Forecast, 2017 – 2023, (USD Million)
Table 3 Cell Therapy Market By Region, 2017 – 2023, (USD Million)
Table 4 Cell Therapy Market By Type, 2017 – 2023, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Cell Therapy Market
Figure 3 Segmentation Market Dynamics For Cell Therapy Market
Figure 4 Global Cell Therapy Market Share, By Type 2016

...Continued
Key Players
Some of key the players in the cell therapy market are Novartis AG, GlaxoSmithKline plc, MEDIPOST, Osiris, PHARMICELL, NuVasive, Inc., JCR Pharmaceuticals Co., Ltd, ANTEROGEN.CO.,LTD., Cynata, CELLECTIS, BioNTech IMFS, EUFETS GmbH, Cognate, Pluristem, Grupo Praxis, Genzyme Corporation, Advanced Tissue and others. 

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/5066

         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Posted by at No comments:
Labels:

Acute Hospital Care Market Research Report 2018 Analysis and Forecast to 2023


Market Scenario:
Acute care is a branch of health care in which short-term treatment is provided to patients with medical conditions such as severe injury and recovery from surgery. Acute conditions such as asthma attack, broken bone, bronchitis, burn, common cold, flu, heart attack, pneumonia, and others require treatment in acute hospital care. Various services are included in acute hospital care such as coronary care, intensive care, neonatal intensive care, cardiology, and others. The acute care market growth is majorly attributed due to the rising incidences of trauma injury, the presence of a large base of the patient population, increasing number of hospital, unmet medical needs in emerging economies. Moreover, the geriatric population having acute diseases are projected to boost the market growth over the forecast period.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4931

According to the American Academy of Allergy, Asthma & Immunology, during 2011-2014, asthma prevalence was 8.8% among all adults. During this period, asthma was more common among adults with obesity (11.1%) compared with adults in normal weight (7.1%) and overweight (7.8%) people.

As per reports from American Academy of Orthopedic Surgeon, broken bones are a common injury i.e an average of 6 million people in the U.S is likely to break a bone each year. Most of these broken bones heal without problems. However, about 300,000 patients are slow to heal or do not heal at all with traditional methods. Since broken bone is a common problem, it needs acute hospital care, Therefore,  it is estimated to fuel the market growth during the forecast period.

However, limited availability of facilities and equipment may hamper the market growth during the forecast period.
The global acute hospital care market is expected to grow at a CAGR of ~7.8% during the forecast period 2017-2023.

Key players for Acute Hospital Care market
Some of key the players in the market are HCA Holdings, Inc. (U.S.), Community Health Systems LLC (U.S.), Universal Health Services, Inc. (U.S.), Tenet Healthcare Corp. (U.S.), Vanguard Health System Inc. (U.S.), Ardent Health Services (U.S.), Kindred Healthcare, Inc. (U.S.), PruittHealth (U.S.), National HealthCare Corp.(U.S.), and others.

Segmentation
The global acute hospital care market is segmented on the basis of medical condition and services.

On the basis of the medical condition, it is segmented into emergency care, urgent care, short-term stabilization, pre-hospital care, critical care, trauma care, and acute care surgery.  

On the basis of the services, it is segmented into coronary care, intensive care, neonatal intensive care, cardiology, and emergency department.

Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/4931
Regional Analysis
The Americas dominate the global acute hospital care market owing to well-developed technology, increasing patient population, high health care spending, and increasing government support for research & development. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the market in this region.
Europe holds the second position in the global acute hospital care market owing to the government support for research & development and availability of funds for research. This is expected to continue to drive the European market over the forecasted period. For instance, developed economies such countries such as Germany and France are increasing investment in the healthcare domain and are focusing more on hospital infrastructure.   
Asia Pacific is the fastest growing acute hospital care market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing demand for acute hospital care in countries like India and South Korea are likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare is projected to lead the use of advanced equipment, which, in turn, may increase the market growth in this region.
On the other hand, the Middle East & Africa holds the least share of the market owing to less availability of funds, limited medical facilities, and deprived political conditions in Africa. 

BRIEF TABLE OF CONTENT
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
Send An Enquiry @  https://www.marketresearchfuture.com/enquiry/4931

         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Posted by at No comments:

Microsurgery Market in depth study and analysis published, 2018


Market Scenario
Microsurgery is a procedure that combines magnification and specialized precision tools & techniques during the surgery. These techniques are majorly used for the treatment of cancer & congenital deficiencies. It helps to heal wounds and restore function after trauma & cancer. The first microsurgery was performed in 1960 by Jules Jacobson.
The major driving factor for the market is increasing prevalence of the cancer, ophthalmic diseases and other chronic diseases. According to Cancer Research UK, in 2012, 14.1 million people across the globe were suffering from cancer. Increasing number of organ transplantation, advances in the surgical procedures and adoption of microscope in surgeries have also driven the market growth. Moreover, high healthcare expenditure, increasing geriatric population, and growing need for the better treatment of the diseases have fueled the market growth. However, high cost of the treatment and poor reimbursement policies for the medical devices may slower the market growth.
The global microsurgery market is expected to grow at a CAGR of 10.2% during the forecast period of 2017-2023.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4214

Key Players        
Some of the key players in microsurgery market are AROSurgical Instruments (US), tisurg medical instruments Co., Ltd (China), Carl Zeiss Meditec AG (Germany), MicroSurgical Technology (US), SYNOVIS MICRO COMPANIES ALLIANCE, INC. (US), Peter LAZIC GmbH (Germany), BIONIKO (US), MICROSURGERY INSTRUMENTS, INC. (US).
Segments    
The global microsurgery market is segmented on the basis of application, procedures, and end users. On the basis of applications the market is categorized into: general surgery, ophthalmology, plastic surgery, gynecological surgery, orthopedic surgery, oncology, neurosurgery, oral & maxillofacial surgery, podiatric surgery, and pediatric surgery.
On the basis of procedures the market is segmented into free tissue transfer, replantation, transplantation, and treatment of infertility. Replantation is further segmented into fingers & thumbs, ear, scalp, nose, and others. Treatment of infertility is further segmented into tubal obstructions, vas deferens obstructions and varicocele.
On the basis of end users the market is segmented into hospitals & clinics, research organizations and others.
Regional Analysis              
The Americas account for the largest share of the global market owing to increasing cancer population, increasing prevalence of neurological diseases and deficiency diseases, and high healthcare spending. According to Centers for Disease Control and Prevention (2014), over 1.5 million cases of invasive cancer, including about 15,000 cases among children younger than 20 years are registered every year. Beside this increasing government support for research & development has supported the growth of the market.
Europe accounts for the second largest market which is followed by Asia Pacific. Availability of funds for research & development, increasing awareness about availability of treatments and well developed healthcare sector drives the market of microsurgery. On the other hand, Asia Pacific holds the fastest growth for microsurgery market owing to increasing number of people suffering from chronic diseases, elevating geriatric population, and demand for better treatments are the key factors for the market growth. China and India holds the major share for the market due to large patient pool.
The Middle East & Africa is expected to show steady growth in this market due to low technology penetration and limited availability of innovative healthcare technologies.
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/4214

Detailed Table of Contents:
1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3 Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
...Continued

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/4214
       
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com


Posted by at No comments:

Wednesday, 11 July 2018

Magnetic Resonance Imaging (MRI) Market Competitive landscape By 2023

Market Scenario
The global Magnetic Resonance Imaging (MRI) Systems market is expected to be of value USD 5 Billion in 2023 and to grow at a depict 3.5% CAGR during the forecast period.  Magnetic resonance imaging (MRI) systems is a non-invasive technique in which light is used to interrogate cellular and molecular function in the living body by exploiting the special properties of photons. Magnetic resonance imaging (MRI) systems are surpassing the radiology imaging market due to its myriad advantages over it. This market is mainly driven by rising demand for non-invasive procedures, harmful effects of radiation-based imaging, increase in research and development activities in the life sciences sector, and increasing application of magnetic resonance imaging (MRI) systems techniques in drug discovery processes and preclinical research, Moreover factors such as rising geriatric population which leads to increase in cardiovascular, neurological and ophthalmic disorders is also fueling the growth of this market. However, the market growth is restricted by factors such as stringent regulatory approval procedures high costs of instruments, scarcity of skilled operators, and insufficient reimbursements policies for magnetic resonance imaging (MRI) systems procedures.
Market Segmentation                                                                                                                          
The global magnetic resonance imaging (MRI) systems market is segmented on the basis of type, field strength, disease application and end user.
Considering the type, the market is segmented into open MRI, closed MRI, standard bore MRI, wide-bore MRI.
On the basis of field strength, the market is segmented into high-field MRI systems, 1.5t MRI systems, 3t MRI systems, low-to-mid-field MRI systems, very-high-field MRI systems, and others.
On account of disease application, the market is segmented into the spine and musculoskeletal MRI, brain and neurological MRI, pelvic and abdominal MRI, breast MRI, cardiovascular MRI, and others
According to the end user, the market is segmented into diagnostic imaging centers, hospitals and clinics, research laboratories, and pharmaceutical &biotechnology companies.
Based on region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. The American region is segmented into North America and South America. Similarly, Europe is segmented into Western Europe and Eastern Europe.
Market Players
  • Hitachi
  • Siemens AG
  • Canon Medical Systems
  • GE Healthcare
  • Philips
  • Toshiba Corporation
  • Toshiba Corporation
  • Xingaoyi
  • Aurora Imaging Technologies, Inc.
Regional Market Summary
In terms of geography, Americas dominates the market for Magnetic Resonance Imaging (MRI) systems owing to increasing prevalence of cardiovascular, neurological and ophthalmic disorders pertaining to rising geriatric population which is a major trigger factor for this disease. Additionally, factors such as increasing government initiatives and funding for research in the medical devices sector, rising demand for accurate diagnosis, awareness about adverse effects of radiation imaging, ability to provide in-depth images of soft tissues and vascular systems, and the presence of pharmaceutical giants also propel the market growth in this region. For instance, according to National Center for Health Statistics report in 2016, around 140,323 mortality occurred due to cerebrovascular disease or stroke in the US Thus, this rising patient pool is going to boost up the market growth during the forecast period.
Europe accounts for the second largest market and holds a healthy share in the global magnetic resonance Imaging (MRI) systems market due to major driving factors like availability of advanced treatment facilities, increasing healthcare expenditure, good healthcare infrastructure and flourishing medical device industry due to the presence of major market players. Additionally, knowledge about the benefits of Magnetic Resonance Imaging (MRI) Systems over radiation imaging and capability of inhabitants to afford the diagnostics is spurring the market growth.
Asia Pacific is expected to be the fastest growing market with most promising growth possibilities. According to a report published by the Department of Neurology in 2014, it is estimated that for the current population of 1.27 billion, approximately 30 million people suffer from neurological disorders in India. Thus, owing to the huge patient pool, a faster adaptation of healthcare technology, government initiatives to increase the healthcare quality, availability favorable insurance policies market growth will be accelerated during the forecast period.  Moreover, due to lower cost of clinical trials and research key players have been setting up their regional headquarters and manufacturing plants in Singapore, China, Japan, Korea, and Australia which make a positive growth curve in  Magnetic Resonance Imaging (MRI) Systems market in future.
 The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates and Saudi Arabia is the largest market share owing to the development of healthcare industry and rising availability of specialty care centers. Hence, the market might show steady growth due to Saudi Arabia, the UAE market growth, and government initiatives to improve quality of healthcare in the Africa region.
Table Of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Measles Market forecast to 2023: Trends & Growth Factors, Top Companies and Detail Research for Business Development

Market Synopsis of Global Measles Market
Market Scenario
Measles also referred as rubeola is a highly contagious disease caused by the rubeola virus. Measles is contracted through exposure to other individuals infected with the rubeola virus. Early symptoms of the disease are fever, red eyes, running nose, and cough. Furthermore, red spots and tiny rashes are observed on the skin of infected person. Measles is spread by a virus belonging to the paramyxovirus family and genus Morbillivirus. This virus first infects only the respiratory tract and then spreads throughout the body.Measles is predominantly a children’s disease, which has been controlled to a large extent today as compared to the past few decades. However, the disease still remains a matter of healthcare worry in most parts of the world. In developed nations, children are commonly provided with vaccination by the age of 18 months to immunize them against the disease. Measles vaccination is not recommended to be administered to a child before the completion of 18 months because an adequate quantity of immunoglobulin is already received via the placenta.
The global measles market is driven by increasing number of people with measles and increasing patients with immunosuppressant diseases. According to the report published by World Health Organization in 1980, measles caused an estimated 2.6 million deaths each year during the period. Additionally, in 2015, approximately 134000 people died globally due to measles. In same year, about 85% of world’s children received one dose of measles vaccine. Number of treatments are available for the measles such as antibiotic treatment, antiviral treatment, vaccine, and others. During the initial stages, the drug treatment is majorly administered. However, vaccines are considered as one of the most efficient ways to prevent the diseases. Patient suffering from immunosuppressant diseases are mostly affected by the disease. Increasing prevalence of autoimmune diseases, increasing need for the better treatment, rapid developments in technology  and increasing government support for research & development have fuelled the growth of the market. However, high cost and limited availability of the treatment may slow the growth of the market over the assessment period.
The global measles market is expected to grow at a CAGR of ~ 5.1 % during the forecast period 2017-2023.
Intended Audience
  • Pharmaceutical Companies
  • Biotechnological Industries
  • Research and Development (R&D) Companies
  • Hospitals and Clinics
  • Academic Institutes and Universities
Segments
The global measles market has been segmented on the basis of types, treatment, and end users.
On the basis of type, the market is segmented into red measles and German measles.
On the basis of treatment, the market is segmented into antibiotic treatment, antiviral treatment, vaccine and others. Vaccines are further segmented into mumps measles rubella vaccine, live (MMR-II) & mumps measles rubella, and varicella virus vaccine (Proquad).
On the basis of end user, the market is segmented into hospital, clinics, and others.

Table Of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry

Regional analysis
The Americas dominates the global measles market owing to well-developed technology and increased patient population with measles. The World Health Organization (WHO) estimates that more than 30 million individuals are affected each year by measles worldwide with more than one million deaths. Vaccination has significantly reduced the number of cases in the United States, although isolated outbreaks continue to occur, and measles has been occurring more frequently in recent years due to an increased number of vaccine refusals. Additionally, increasing prevalence of the immunological diseases, high healthcare expenditure, and the presence of some of the leading players have fuelled the growth of the market in this region.
Europe is the second largest measles market, which is followed by Asia Pacific. Increasing government support and availability of funds for research drive the growth of the market. Asia Pacific is the fastest growing measles market due to a huge population base and rapidly developing medical sector.
On the other hand, the Middle East & Africa holds the least share of the market due to limited availability of medical facilities and poor economic and political conditions in Africa. However, African regions is expected to be the fastest growing market over the review period.

Key Players
Some of key players profiled in the report are Abbott (US), Novartis AG (Switzerland), Biomedical diagnostics (US), Johnson & Johnson Services, Inc. (US), Sanofi (US), Merck & Co., Inc. (US), Serum Institute of India Pvt. Ltd. (India), Bavarian Nordic (Denmark), MedImmune (US Astellas Pharma Inc. (Japan), CSL Limited (Australia), Emergent BioSolutions Inc. (US), and GlaxoSmithKline plc (US), and others. 
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Posted by at No comments:

Global Melanoma Market Analysis 2018 Forecasts to 2023

Market Scenario:
Melanoma is a type of cancer that develops from pigment containing cells known as melanocytes. It is the most dangerous type of skin cancer. Sometimes they develop from moles showing significant change in color, increase in size, itchiness, irregular edges, changein color or skin breakdown. Exposure to ultra violet light in people with low pigment levels. The tumor can be either malignant or benign. Types of melanoma are superficial spreading melanoma, nodular melanoma, lentigo maglina melanoma, acral lentigious melanoma and others. About 98% of melanoma is localized in the US. Skin cancer are most common cancers in the US. Treatment available for melanoma include biologic therapy, immune therapy, radiation therapy, chemotherapy and surgery. Ultra violet exposure is known as risk factor of melanoma. Superficial spreading melanoma is the type of melanoma affecting large number of people in the US. The disease is more common in men than women.
The US market of melanoma is expected to reach US$ 3.2 billion in 2023 from US$ 2.4 billion in 2016 with a CAGR of approximately 8.3%.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/2950

Segments:

US melanoma market has been segmented on the basis of type (superficial spreading, nodular, lentigo maglina, acral lentigious and others), by gender (male and female), by treatment (immunotherapy, biologic therapy, radiation therapy, chemotherapy, surgery and others), by diagnosis (ABCDE, ugly duckling, biopsy, and others) and by end users (hospitals, pharmaceutical companies, research centers, clinics, laboratories).
Regional Analysis of Melanoma Market:
Melanoma market in the US is divided into states comprising of Georgia, New Jersey, North Carolina, New York, Florida, Illinois, Ohio, Pennsylvania, Texas, Washington, California and, Virginia and Rest of US. California accounts for the largest market for melanoma in US followed by Florida and Ohio. California and Florida are key regions for melanoma market. Large number of melanoma cases are found in this region.  New York is the third largest market after Florida. According to American Society of Dermatology, prevalence of melanoma is gradually increasing.  and this spreads across the body. Number of skin cancer patients is growing steadily in Florida and Texas. This is due to their exposure to ultraviolet rays and extensive use of tanning beds in these regions. Technological advancement in the field of treatment and diagnosis of melanoma in the US also drives this market. The Food and Drug Administration (FDA) classifies tanning beds as "moderate risk" devices.
Key Players for Melanoma Market:
Some of the Key Players in this market are: Amgen, Inc., Bristol-Myers Squibb, Eisai Co. Ltd., F. Hoffmann-La Roche Ltd., Genentech Inc. Janssen Biotech, Inc., and Novartis International AG. Pfizer, Vical and Ziopharm.
Intended Audience
Hospitals
Pharmaceutical companies
Research and development (R&D) companies
Academic medical institutes and universities
Melanoma drug manufactures
Melanoma drug suppliers


Detailed Table of Contents:
1 Report Prologue
2 Market Introduction
2.1 Introduction
2.2 Scope Of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Awareness Regarding Skin Cancer
4.1.2 Increased Emphasis On Early Detection Of Cancer
4.1.3 Increasing Inclination Towards Preventive Care
4.2 Restrains
4.2.1 Risk Associated With Blood Transfusion
5 Market Factor Analysis
5.1 Porter’s Five Forces Model
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry

...Continued

         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Subscribe to: Posts (Atom)